Malignant tumor of rectum (disorder)
Clinical Trial: CEDAR
Year Started: 2019
A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Paraffin | Not applicable | 0 - 10% | |
| Whole blood | RT | Not applicable | 0 - 10% |
Female
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Paraffin | Not applicable | 0 - 10% | |
| Whole blood | RT | Not applicable | 0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Not applicable | 0 - 10% | ||
| Whole blood | RT | Not applicable | 0 - 10% | ||
| Faeces | RT | Not applicable | 0 - 10% |
Male
Adult (> 40 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Faeces | RT | Not applicable | 0 - 10% | ||
| RNA | -60°C to -85°C | Not applicable | 0 - 10% | ||
| Tissue specimen | RT | Not applicable | 0 - 10% | ||
| Whole blood | RT | Not applicable | 0 - 10% |